Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 6 (2009), Issue 8 (August)

1. Treatment strategies in surgery for rheumatoid arthritis.
   Eur J Radiol, 71(2): 204-10. [Abstract] [Full-text]
2. Lymphocyte transformation test is not helpful for the diagnosis of methotrexate-induced pneumonitis in patients with rheumatoid arthritis.
   Clin Chim Acta, 407(1): 25-9. [Abstract] [Full-text]
3. Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease.
   Eur Heart J, 30(15): 1837-43. [Abstract] [Full-text]
4. MRI quantification of rheumatoid arthritis: current knowledge and future perspectives.
   Eur J Radiol, 71(2): 189-96. [Abstract] [Full-text]
5. Does the Comprehensive International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis capture nursing practice? A Delphi survey.
   Int J Nurs Stud, 46(10): 1320-34. [Abstract] [Full-text]
6. Quantification of synovitis in rheumatoid arthritis: do we really need quantitative measurement of contrast-enhanced ultrasound?
   Eur J Radiol, 71(2): 237-41. [Abstract] [Full-text]
7. Breaking old paradigms: Th17 cells in autoimmune arthritis.
   Clin Immunol, 132(3): 295-304. [Abstract] [Full-text]
8. Early rheumatoid arthritis and its differentiation from other joint abnormalities.
   Eur J Radiol, 71(2): 217-24. [Abstract] [Full-text]
9. Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland.
   Exp Eye Res, 89(3): 319-32. [Abstract] [Full-text]
10. Quantification of synovial and erosive changes in rheumatoid arthritis with ultrasound--revisited.
    Eur J Radiol, 71(2): 225-31. [Abstract] [Full-text]
11. The effect of rheumatoid arthritis on the anatomy of the female cervical spine: a radiological study.
    J Bone Joint Surg Br, 91(8): 1058-63. [Abstract] [Full-text]
12. Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis.
    Mod Rheumatol, 19(4): 351-7. [Abstract] [Full-text]
13. Cardiac tamponade in Still disease: a review of the literature.
    South Med J, 102(8): 832-7. [Abstract] [Full-text]
14. The composite DAS Score is impractical to use in daily practice: evidence that physicians use the objective component of the DAS in decision making.
    J Clin Rheumatol, 15(5): 223-5. [Abstract] [Full-text]
15. Evaluation of the internet for finding persons with undiagnosed rheumatoid arthritis and systemic lupus erythematosus.
    J Clin Rheumatol, 15(5): 218-22. [Abstract] [Full-text]
16. Measuring educational needs among patients with rheumatoid arthritis using the Dutch version of the Educational Needs Assessment Tool (DENAT).
    Clin Rheumatol, 28(9): 1073-7. [Abstract] [Full-text]
17. Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis.
    Clin Rheumatol, 28(9): 1113-6. [Abstract] [Full-text]
18. Rheumatoid leptomeningitis: rare complication of rheumatoid arthritis.
    Clin Rheumatol, 28(9): 1117-9. [Abstract] [Full-text]
19. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
    Lancet, 374(9688): 459-66. [Abstract] [Full-text]
20. Inhibition of HIF-1alpha activity by BP-1 ameliorates adjuvant induced arthritis in rats.
    Biochem Biophys Res Commun, 387(2): 223-8. [Abstract] [Full-text]
21. Cells with regulatory function of the innate and adaptive immune system in primary Sjögren's syndrome.
    Clin Exp Immunol, 157(3): 343-9. [Abstract] [Full-text]
22. Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study.
    Arthritis Rheum, 61(8): 1077-86. [Abstract] [Full-text]
23. Spouse depression and disease course among persons with rheumatoid arthritis.
    Arthritis Rheum, 61(8): 1011-7. [Abstract] [Full-text]
24. Effectiveness of two finger splints for swan neck deformity in patients with rheumatoid arthritis: a randomized, crossover trial.
    Arthritis Rheum, 61(8): 1025-31. [Abstract] [Full-text]
25. Depression, inflammation, and pain in patients with rheumatoid arthritis.
    Arthritis Rheum, 61(8): 1018-24. [Abstract] [Full-text]
26. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
    Arthritis Rheum, 60(8): 2294-303. [Abstract] [Full-text]
27. Methotrexate catabolism to 7-hydroxymethotrexate in rheumatoid arthritis alters drug efficacy and retention and is reduced by folic acid supplementation.
    Arthritis Rheum, 60(8): 2257-61. [Abstract] [Full-text]
28. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    Arthritis Rheum, 60(8): 2232-41. [Abstract] [Full-text]
29. Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritis.
    Arthritis Rheum, 60(8): 2242-7. [Abstract] [Full-text]
30. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Arthritis Rheum, 60(8): 2248-56. [Abstract] [Full-text]
31. Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis.
    Arthritis Rheum, 60(8): 2272-83. [Abstract] [Full-text]
32. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.
    Arthritis Rheum, 60(8): 2262-71. [Abstract] [Full-text]
33. DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists.
    BMC Musculoskelet Disord, 10: 91. [Abstract] [Full-text]
34. Therapeutic options for rheumatoid arthritis.
    Expert Opin Pharmacother, 10(13): 2095-106. [Abstract] [Full-text]
35. Prediction of efficacy of anti-TNF biologic agent, infliximab, for rheumatoid arthritis patients using a comprehensive transcriptome analysis of white blood cells.
    Biochem Biophys Res Commun, 387(2): 261-5. [Abstract] [Full-text]
36. The OMERACT ultrasound task force -- Advances and priorities.
    J Rheumatol, 36(8): 1829-32. [Abstract] [Full-text]
37. Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection -- Does it change the assessment of inflammatory and destructive joint changes by the OMERACT RAMRIS?
    J Rheumatol, 36(8): 1806-10. [Abstract] [Full-text]
38. The OMERACT MRI inflammatory arthritis group: advances and future research priorities.
    J Rheumatol, 36(8): 1803-5. [Abstract] [Full-text]
39. Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers.
    J Rheumatol, 36(8): 1800-2. [Abstract] [Full-text]
40. Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis: a systematic literature search on 5 candidate biomarkers.
    J Rheumatol, 36(8): 1769-84. [Abstract] [Full-text]
41. Cartilage oligomeric matrix protein in patients with juvenile idiopathic arthritis: relation to growth and disease activity.
    J Rheumatol, 36(8): 1749-54. [Abstract] [Full-text]
42. Increased prevalence of antibodies to thyroid peroxidase in dry eyes and mouth syndrome or sicca asthenia polyalgia syndrome.
    J Rheumatol, 36(8): 1626-30. [Abstract] [Full-text]
43. Increased frequency of gastrointestinal symptoms in patients with fibromyalgia and associated factors: a comparative study.
    J Rheumatol, 36(8): 1720-4. [Abstract] [Full-text]
44. Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, eotaxin-3, and MHC2TA.
    J Rheumatol, 36(8): 1590-5. [Abstract] [Full-text]
45. Biomarkers of chronic uveitis in juvenile idiopathic arthritis: predictive value of antihistone antibodies and antinuclear antibodies.
    J Rheumatol, 36(8): 1737-43. [Abstract] [Full-text]
46. Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and C-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritis.
    J Rheumatol, 36(8): 1606-10. [Abstract] [Full-text]
47. A followup study of asymptomatic carriers of Pneumocystis jiroveci during immunosuppressive therapy for rheumatoid arthritis.
    J Rheumatol, 36(8): 1600-5. [Abstract] [Full-text]
48. Expression and function of histone deacetylases in rheumatoid arthritis synovial fibroblasts.
    J Rheumatol, 36(8): 1580-9. [Abstract] [Full-text]
49. Th1 and Th17 Predominance in the Enthesitis-related Arthritis Form of Juvenile Idiopathic Arthritis.
    J Rheumatol, 36(8): 1730-6. [Abstract] [Full-text]
50. Surfing for juvenile idiopathic arthritis: perspectives on quality and content of information on the Internet.
    J Rheumatol, 36(8): 1755-62. [Abstract] [Full-text]
51. Declines in erythrocyte sedimentation rates in patients with rheumatoid arthritis over the second half of the 20th century.
    J Rheumatol, 36(8): 1596-9. [Abstract] [Full-text]
52. Ankle disease in juvenile idiopathic arthritis: ultrasound findings in clinically swollen ankles.
    J Rheumatol, 36(8): 1725-9. [Abstract] [Full-text]
53. Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study.
    J Rheumatol, 36(8): 1611-7. [Abstract] [Full-text]
54. B cell depletion in lupus and Sjögren's syndrome: an update.
    Curr Opin Rheumatol, 21(5): 483-8. [Abstract] [Full-text]
55. Genetics of systemic lupus erythematosus and Sjögren's syndrome.
    Curr Opin Rheumatol, 21(5): 448-53. [Abstract] [Full-text]
56. Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome.
    Curr Opin Rheumatol, 21(5): 443-7. [Abstract] [Full-text]
57. Pathogenesis of Sjögren's syndrome.
    Curr Opin Rheumatol, 21(5): 465-70. [Abstract] [Full-text]
58. The working space of the hand in rheumatoid arthritis: its impact on disability.
    J Hand Surg Eur Vol, 34(4): 465-70. [Abstract] [Full-text]
59. Influence of age on the outcome of antitumour necrosis factor alpha therapy in rheumatoid arthritis.
    Ann Rheum Dis, 68(9): 1470-3. [Abstract] [Full-text]
60. Homozygosity for DNASE2 single nucleotide polymorphisms in the 5'-regulatory region is associated with rheumatoid arthritis.
    Ann Rheum Dis, 68(9): 1498-503. [Abstract] [Full-text]
61. Is the blood B-cell subset profile diagnostic for Sjogren syndrome?
    Ann Rheum Dis, 68(9): 1447-52. [Abstract] [Full-text]
62. Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA).
    Ann Rheum Dis, 68(9): 1486-93. [Abstract] [Full-text]
63. Evidence of epistasis between interleukin 1 and selenoprotein-S with susceptibility to rheumatoid arthritis.
    Ann Rheum Dis, 68(9): 1494-7. [Abstract] [Full-text]
64. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation.
    Ann Rheum Dis, 68(9): 1395-400. [Abstract] [Full-text]
65. Gene expression and chromosomal location for susceptibility to Sjögren's syndrome.
    J Autoimmun, 33(2): 99-108. [Abstract] [Full-text]
66. Thrombin-sensitive photodynamic agents: a novel strategy for selective synovectomy in rheumatoid arthritis.
    J Control Release, 138(3): 225-34. [Abstract] [Full-text]
67. Endogenous glutamate in association with inflammatory and hormonal factors modulates bone tissue resorption of the temporomandibular joint in patients with early rheumatoid arthritis.
    J Oral Maxillofac Surg, 67(9): 1895-903. [Abstract] [Full-text]
68. Single-stage comprehensive surgical treatment of the rheumatoid arthritis temporomandibular joint patient.
    J Oral Maxillofac Surg, 67(9): 1859-72. [Abstract] [Full-text]
69. Depression in RA patients treated with anti-TNF is common and under-recognized in the rheumatology clinic.
    Rheumatology (Oxford), 48(9): 1152-4. [Abstract] [Full-text]
70. Early rheumatoid arthritis and body composition.
    Rheumatology (Oxford), 48(9): 1128-32. [Abstract] [Full-text]
71. A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis.
    Rheumatology (Oxford), 48(9): 1114-21. [Abstract] [Full-text]
72. Presentation and severity of rheumatoid arthritis at diagnosis in Senegal.
    Rheumatology (Oxford), 48(9): 1111-3. [Abstract] [Full-text]
73. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
    Rheumatology (Oxford), 48(9): 1107-10. [Abstract] [Full-text]
74. Cytokine and autoantibody profiling related to histopathological features in primary Sjogren's syndrome.
    Rheumatology (Oxford), 48(9): 1102-6. [Abstract] [Full-text]
75. Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse.
    Rheumatology (Oxford), 48(9): 1092-7. [Abstract] [Full-text]
76. Health-related quality of life, employment and disability in patients with Sjogren's syndrome.
    Rheumatology (Oxford), 48(9): 1077-82. [Abstract] [Full-text]
77. Bone mineral density in the hand as a predictor for mortality in patients with rheumatoid arthritis.
    Rheumatology (Oxford), 48(9): 1088-91. [Abstract] [Full-text]
78. Can rheumatoid arthritis responsiveness to methotrexate and biologics be predicted?
    Rheumatology (Oxford), 48(9): 1021-8. [Abstract] [Full-text]
79. Detection of disease-associated deletions in case-control studies using SNP genotypes with application to rheumatoid arthritis.
    Hum Genet, 126(2): 303-15. [Abstract] [Full-text]
80. Expression and citrullination of keratin in synovial tissue of rheumatoid arthritis.
    Rheumatol Int, 29(11): 1337-42. [Abstract] [Full-text]
81. Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis.
    Rheumatol Int, 29(11): 1315-21. [Abstract] [Full-text]
82. Adding low dose tacrolimus in rheumatoid arthritis patients with an inadequate response to tumor necrosis factor inhibitor therapies.
    Rheumatol Int, 29(11): 1287-91. [Abstract] [Full-text]
83. An unusual central nervous system involvement in rheumatoid arthritis: combination of pachymeningitis and cerebral vasculitis.
    Rheumatol Int, 29(11): 1349-53. [Abstract] [Full-text]
84. Fatal myocarditis in adult-onset Still disease with diffuse intravascular coagulation.
    Rheumatol Int, 29(11): 1355-7. [Abstract] [Full-text]
85. A clinical perspective of rheumatoid arthritis.
    Eur J Immunol, 39(8): 2044-8. [Abstract] [Full-text]
86. Animal models of rheumatoid arthritis.
    Eur J Immunol, 39(8): 2040-4. [Abstract] [Full-text]
87. Sjogren's syndrome myelopathy: spinal cord involvement in Sjogren's syndrome might be a manifestation of neuromyelitis optica.
    Mult Scler, 15(9): 1062-8. [Abstract] [Full-text]
88. Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: association with neuromyelitis optica.
    Mult Scler, 15(9): 1069-76. [Abstract] [Full-text]
89. Pleuropulmonary complications of rheumatoid arthritis: a thoracic surgeon's challenge.
    Ann Thorac Surg, 88(3): e20-1. [Abstract] [Full-text]
90. Increased expression of activation-induced cytidine deaminase is associated with anti-CCP and rheumatoid factor in rheumatoid arthritis.
    Scand J Immunol, 70(3): 309-16. [Abstract] [Full-text]
91. Increase in human endogenous retrovirus HERV-K (HML-2) viral load in active rheumatoid arthritis.
    Scand J Immunol, 70(3): 295-9. [Abstract] [Full-text]
92. Flow cytometric analysis of phospho-p38 mitogen-activated kinase (MAPK): p38 MAPK does not mediate the effect of adalimumab on peripheral T cell cytokine production in rheumatoid arthritis.
    Cytokine, 47(3): 178-84. [Abstract] [Full-text]
93. Prognostic factors in rheumatoid arthritis in the era of biologic agents.
    Nat Rev Rheumatol, 5(9): 491-6. [Abstract] [Full-text]
94. Presence of Mycoplasma fermentans in the bloodstream of Mexican patients with rheumatoid arthritis and IgM and IgG antibodies against whole microorganism.
    BMC Musculoskelet Disord, 10: 97. [Abstract] [Full-text]
95. Lowering interleukin-1 activity with anakinra improves myocardial deformation in rheumatoid arthritis.
    Heart, 95(18): 1502-7. [Abstract] [Full-text]
96. Reliability, validity and responsiveness of a new leisure index: the Patient-Specific Leisure Scale (PSLS).
    Musculoskeletal Care, 7(3): 178-93. [Abstract] [Full-text]
97. The impact of patient-perceived restricted access to anti-TNF therapy for rheumatoid arthritis: a qualitative study.
    Musculoskeletal Care, 7(3): 194-209. [Abstract] [Full-text]

© 2004-2012 Rheumatoid Arthritis Research Today. All Rights Reserved.